These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38295186)

  • 1. Integrating the gut microbiome and pharmacology.
    Verdegaal AA; Goodman AL
    Sci Transl Med; 2024 Jan; 16(732):eadg8357. PubMed ID: 38295186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human gut microbiota plays a role in the metabolism of drugs.
    Jourova L; Anzenbacher P; Anzenbacherova E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):317-26. PubMed ID: 27485182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability Based on the Gut Microbiota: a New Perspective.
    Zhang F; He F; Li L; Guo L; Zhang B; Yu S; Zhao W
    Microbiol Mol Biol Rev; 2020 May; 84(2):. PubMed ID: 32350027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between drugs and the gut microbiome.
    Weersma RK; Zhernakova A; Fu J
    Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery.
    Kamath S; Stringer AM; Prestidge CA; Joyce P
    Expert Opin Drug Deliv; 2023; 20(10):1315-1331. PubMed ID: 37405390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome interactions with drug metabolism, efficacy, and toxicity.
    Wilson ID; Nicholson JK
    Transl Res; 2017 Jan; 179():204-222. PubMed ID: 27591027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.
    Enright EF; Joyce SA; Gahan CG; Griffin BT
    Mol Pharm; 2017 Apr; 14(4):1251-1263. PubMed ID: 28186768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota as an "invisible organ" that modulates the function of drugs.
    Li X; Liu L; Cao Z; Li W; Li H; Lu C; Yang X; Liu Y
    Biomed Pharmacother; 2020 Jan; 121():109653. PubMed ID: 31810138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems biology perspective for studying the gut microbiota in human physiology and liver diseases.
    Altay O; Nielsen J; Uhlen M; Boren J; Mardinoglu A
    EBioMedicine; 2019 Nov; 49():364-373. PubMed ID: 31636011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Metabolism of Xenobiotics by Gut Microbiota.
    Nakov R; Velikova T
    Curr Drug Metab; 2020; 21(4):260-269. PubMed ID: 32124693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Drug Metabolism by the Gut Microbiota: Modes of Metabolism and Experimental Approaches.
    Dhurjad P; Dhavaliker C; Gupta K; Sonti R
    Drug Metab Dispos; 2022 Mar; 50(3):224-234. PubMed ID: 34969660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs.
    Noh K; Kang YR; Nepal MR; Shakya R; Kang MJ; Kang W; Lee S; Jeong HG; Jeong TC
    Arch Pharm Res; 2017 Dec; 40(12):1345-1355. PubMed ID: 29181640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota: what is its place in pharmacology?
    Tarasiuk A; Fichna J
    Expert Rev Clin Pharmacol; 2019 Oct; 12(10):921-930. PubMed ID: 31544557
    [No Abstract]   [Full Text] [Related]  

  • 14. Universal gut microbial relationships in the gut microbiome of wild baboons.
    Roche KE; Bjork JR; Dasari MR; Grieneisen L; Jansen D; Gould TJ; Gesquiere LR; Barreiro LB; Alberts SC; Blekhman R; Gilbert JA; Tung J; Mukherjee S; Archie EA
    Elife; 2023 May; 12():. PubMed ID: 37158607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome Medicine: Microbiota in Development and Management of Cardiovascular Diseases.
    Garg Y; Kanwar N; Chopra S; Tambuwala MM; Dodiya H; Bhatia A; Kanwal A
    Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1344-1356. PubMed ID: 35761484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism.
    Enright EF; Griffin BT; Gahan CGM; Joyce SA
    Pharmacol Res; 2018 Jul; 133():170-186. PubMed ID: 29660405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized Mapping of Drug Metabolism by the Human Gut Microbiome.
    Javdan B; Lopez JG; Chankhamjon P; Lee YJ; Hull R; Wu Q; Wang X; Chatterjee S; Donia MS
    Cell; 2020 Jun; 181(7):1661-1679.e22. PubMed ID: 32526207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of gut microbiota on drug metabolism and toxicity.
    Li H; He J; Jia W
    Expert Opin Drug Metab Toxicol; 2016; 12(1):31-40. PubMed ID: 26569070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.
    Aziz RK; Hegazy SM; Yasser R; Rizkallah MR; ElRakaiby MT
    Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1043-1055. PubMed ID: 30269615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-gut microbiota interactions: implications for neuropharmacology.
    Walsh J; Griffin BT; Clarke G; Hyland NP
    Br J Pharmacol; 2018 Dec; 175(24):4415-4429. PubMed ID: 29782640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.